News
UnitedHealth, Amedisys and the DOJ reached a settlement last week, clearing the way for the deal to be finalized. Amedisys ...
On August 7, the DOJ and four state attorneys general announced a settlement to resolve their challenge to the $3.3 billion ...
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best high-volume stocks to invest in. On August 7, UnitedHealth and ...
The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...
GlobalData on MSN5d
UnitedHealth’s $3.3bn Amedisys deal faces strict divestiture terms
UnitedHealth faced legal challenges last year when the US Justice Department and state attorneys general moved to block the ...
Unitedhealth Group Inc. and home health and hospice care company Amedisys Inc. have reached a proposed a settlement with the ...
TipRanks on MSN2d
M&A News: UnitedHealth (UNH) Closes $3.3B Amedisys Deal After Two-Year Antitrust Battle
Health insurer UnitedHealth (UNH) has finally completed its $3.3 billion acquisition of Amedisys, a home health and hospice ...
UnitedHealth Group completed its $3.3 billion purchase of Baton Rouge-based Amedisys Thursday morning, more than two years ...
UNH advanced 1.17% in after-hours trading to $275 on Wednesday, following the company’s announcement of a $2.21 quarterly ...
Today, UnitedHealth Group (NYSE: UNH) and Amedisys tied a bow on their merger. The deal – after being beleaguered by the DOJ’s attempt at blocking it – ...
Zacks Investment Research on MSN4d
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
UnitedHealth Group Incorporated UNH recently reached a settlement with the DOJ to advance its $3.3 billion acquisition of ...
Both companies were required by the DOJ to divest more than 160 businesses across 19 states to allow the deal to continue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback